Autoimmune Gastroenteritis and Related Autoimmune Diseases: Clinical Significance and Diagnostics

Autoimmune gastroenteritis represents a group of disorders in which the immune system mistakenly attacks tissues within the gastrointestinal tract. This leads to chronic inflammation, impaired nutrient absorption, deficiencies, and systemic complications. Early diagnosis is essential, as these conditions often progress silently and are detected late.

Modern serological panels, including those developed by TestLine, support the identification of specific autoantibodies associated with various autoimmune diseases affecting the gastrointestinal system.

1. Celiac Disease (Gluten‑Sensitive Enteropathy)

Celiac disease is a chronic autoimmune disorder in which gluten intake triggers an immune response that damages the lining of the small intestine. This results in malabsorption, diarrhea, bloating, anemia, and vitamin deficiencies.

Key Autoantibodies:

• tTG (tissue transglutaminase)

• DAG (deamidated gliadin peptides)

These markers are among the most sensitive and specific for diagnosing and monitoring celiac disease. Their detection supports early diagnosis and evaluation of the response to a gluten‑free diet.

2. Autoimmune Gastritis and Pernicious Anemia

Autoimmune gastritis is a chronic inflammation of the stomach lining caused by autoantibodies targeting parietal cells and intrinsic factor. This leads to reduced gastric acid secretion and impaired absorption of vitamin B12.

Key Autoantibodies:

• APCA (anti‑parietal cell antibodies)

• IF (intrinsic factor antibodies)

These antibodies are characteristic of autoimmune gastritis and pernicious anemia. Early detection is crucial to prevent severe deficiencies and neurological complications.

3. Inflammatory Bowel Diseases (IBD)

Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, have a complex immunological basis. Although not classic autoimmune diseases, serological markers assist in differential diagnosis.

Key Autoantibodies:

• ASCA (anti‑Saccharomyces cerevisiae antibodies)

ASCA is commonly associated with Crohn’s disease and is often used to distinguish it from ulcerative colitis, especially in unclear clinical cases.

4. Autoimmune Liver Diseases

Some autoantibodies included in gastroenteritis panels are also relevant for diagnosing autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis.

Key Autoantibodies:

• MPO (myeloperoxidase)

These markers help differentiate autoimmune processes that may affect both the liver and the gastrointestinal tract.

Why Serological Panels Matter

Autoimmune gastroenteritis often presents with nonspecific symptoms such as fatigue, bloating, diarrhea, anemia, and weight loss. Serological panels enable:

• early detection of autoimmune activity

• differentiation between various gastrointestinal disorders

• confirmation of screening test results

• monitoring disease activity

• more accurate clinical assessment and treatment planning

This makes them a valuable tool for both gastroenterologists and clinical laboratories.

Sample Collection

Venous blood